Towards Personalized Medicine for OCD
1 other identifier
interventional
178
1 country
1
Brief Summary
Obsessive compulsive disorder (OCD) is one of the most disabling anxiety disorders occurring in about 2 out of a 100 adults. Untreated, OCD is a chronic and deteriorating condition, negatively impacting multiple areas of life with high personal and socioeconomic costs. In Denmark, anxiety disorders are estimated to be the most expensive of all psychiatric disorders and the most common reason for forced retirement. In many countries including DK, CBT is the recommended, first-line treatment for OCD. All individuals who seek treatment in the Danish Regions are offered CBT. However, reviews show that up to 50% of patients either do not respond to CBT or terminate treatment prematurely. Despite this large number of non-responders, no significant progress for OCD treatment has been made since initial efficacy trials. Alternatives to CBT are needed . Acceptance and Commitment therapy (ACT) is an innovative psychotherapy that can potentially help individuals with OCD who do not benefit from CBT. ACT targets the habitual thinking and behaviors that mark OCD by aiming to increase value-based behavior. OCD often co-occurs with depression and other anxiety disorders making treatment more difficult. ACT is a transdiagnostic treatment targeting symptoms that are common to anxiety and mood disorders. Preliminary findings indicate that ACT may be an effective treatment for OCD. However, these findings constitute a low level of evidence. Before ACT can be declared as an effective treatment for OCD, it needs to be demonstrated in randomize controlled trials, in which ACT is compared to legitimate, active treatments, such as CBT. This project will test the effectiveness of group-based ACT by comparing it to the first-line treatment, group-CBT in 180 participants referred for treatment in a specialized outpatient clinic at the Mental Health Services, Capital Region of Denmark. Furthermore, moderators and predictors of treatment response will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2019
CompletedFirst Posted
Study publicly available on registry
February 25, 2019
CompletedStudy Start
First participant enrolled
March 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2025
CompletedJune 29, 2025
February 1, 2019
4.5 years
February 18, 2019
June 25, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Yale Brown obsessive compulsive scale
Semi-structured interview, total score consists of all items of all items summed up, likert scale minimum 0- maximum 4, higher values predict worse OCD-symptoms
25 minutes
Quality of Life Inventory
Self-report measure, 16 items, minimum -3 - maximum 3. Higher scores indicate higher quality of life. measuring outcome in terms of an overall life satisfaction score, likert scale 0-6
20 minutes
Study Arms (2)
Cognitive behavioral therapy
ACTIVE COMPARATORManualized group-based cognitive behavioual therapy delivered by clinical psychologists and psychiatrists. The treatment consists of 14 sessions of each 2 hours.
Acceptance and commitment therapy
EXPERIMENTALManualized group-based Acceptance and Commitment therapy delivered by clinical psychologists and psychiatrists. The treatment consists of 14 sessions of each 2 hours.
Interventions
Group based psychotherapy
Eligibility Criteria
You may qualify if:
- have OCD as their primary diagnosis
- are between 18-65 years
- are free of alcohol and substance abuse
- are not receiving any other psychotherapy during the study
- are medication-free or stabilized on psychotropic medication
- speak and understand Danish
- provide written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Copenhagen
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Assessor blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Researcher
Study Record Dates
First Submitted
February 18, 2019
First Posted
February 25, 2019
Study Start
March 2, 2019
Primary Completion
August 31, 2023
Study Completion
June 25, 2025
Last Updated
June 29, 2025
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share